End-stage renal disease (ESRD) represents an advanced stage of kidney disease in which patients require specialized treatment, including dialysis or kidney transplantation. The market encompasses treatment options, equipment, and technologies designed to support patients whose kidneys can no longer adequately perform their essential functions. Growing demand for renal care is encouraging healthcare providers and medical technology companies to expand treatment capabilities and improve access to care.

According to the market report, the end-stage renal disease market was valued at USD 99.1 billion in 2022. The report lists a market size of USD 111.2 billion in 2023 and projects the market to reach USD 261.64 billion by 2030, registering a compound annual growth rate (CAGR) of 13.0% from 2023 to 2030.

Download a free sample copy of the End Stage Renal Disease market report to understand detailed coverage and inclusions in the final report

Important Market Highlights

·         Market size: USD 99.1 billion in 2022.

·         Market size in 2023: USD 111.2 billion.

·         Market forecast: USD 261.64 billion by 2030.

·         Growth rate: 13.0% CAGR from 2023 to 2030.

·         Leading treatment segment: Dialysis, accounting for more than 77.5% of revenue in 2022.

·         Leading regional market: Asia Pacific, with a revenue share of more than 37.4% in 2022.

·         Key treatment categories: Dialysis and transplantation.

Rising Kidney Disease Burden Supports Treatment Demand

The increasing number of people affected by kidney failure and chronic kidney disease is an important factor supporting market expansion. Diabetes and high blood pressure are identified as major risk factors for kidney disease, creating a greater need for ongoing renal care and specialized treatment services.

The report also highlights the importance of hospital infrastructure, urgent care facilities, and hospital admissions in shaping market demand. Patients with advanced kidney disease often require continuing treatment, making the availability of suitable facilities, equipment, and clinical services essential to the delivery of care.

Growing awareness of kidney-related conditions is another factor influencing demand. Earlier recognition of kidney disease and greater understanding of available treatment options can help patients and healthcare providers make informed decisions about managing advanced disease.

Dialysis Remains the Core Treatment Segment

Dialysis dominated the market in 2022, accounting for more than 77.5% of total revenue. Its leading position reflects its accessibility compared with transplantation, which depends on the availability of suitable donor organs and other clinical considerations.

Dialysis treatment includes hemodialysis and peritoneal dialysis. Hemodialysis uses specialized equipment to filter waste and excess fluid from the blood, while peritoneal dialysis uses the lining of the abdomen as a filtering membrane. Treatment can take place in dialysis centers or, where appropriate, at home.

The report expects dialysis to maintain strong growth during the forecast period. Its established role in renal care, the need for continuing treatment, and the limited availability of donor organs contribute to its importance within the market.

Technology Is Expanding Renal Treatment Options

Medical technology innovation is creating opportunities to improve the delivery of renal care. The report identifies low-maintenance dialysis equipment and artificial kidney technologies among the developments supporting market growth.

Advances in dialysis equipment can help address operational requirements across healthcare facilities and home-based treatment settings. Home dialysis has also gained attention as patients and providers explore alternatives to repeated visits to medical centers. Its suitability depends on individual clinical needs, available support, and treatment requirements.

Wearable artificial kidney technology is another treatment area included in the report's market segmentation. These developments reflect continued efforts to expand the range of renal replacement options available to patients.

Regional Developments Shape Market Opportunities

Asia Pacific accounted for more than 37.4% of market revenue in 2022, making it the leading regional market identified in the report. Its position is associated with a large population base, the burden of diabetes and hypertension, an aging population, and improvements in diagnosis and patient affordability.

The region is also expected to register the fastest CAGR during the forecast period. Increasing healthcare access and opportunities to introduce affordable medical products are important considerations for companies seeking to expand their presence.

The Middle East and Africa region is also identified as an area with substantial growth potential. The report discusses the influence of chronic kidney disease prevalence, demographic factors, and socioeconomic conditions on regional treatment requirements.

FAQs

1. How big is the end-stage renal disease market?

The market was valued at USD 99.1 billion in 2022. The report lists USD 111.2 billion for 2023 and projects the market to reach USD 261.64 billion by 2030.

2. What trends are shaping the end-stage renal disease market?

Key developments include advances in dialysis equipment, increasing interest in home dialysis, artificial kidney technologies, and efforts to improve treatment accessibility. Growing demand for renal care and the expansion of healthcare infrastructure are also influencing the market.

Key End Stage Renal Disease Companies:

·        Nipro Corp.

·        Fresenius Medical Care AG & Co. KGaA

·        Baxter International, Inc.

·        Medtronic Plc

Explore the full list of profiled companies operating in this market with recent strategic initiatives

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.